Skip to main content
Shaperon Inc. logo

Shaperon Inc. — Investor Relations & Filings

Ticker · 378800 ISIN · KR7378800007 KO Manufacturing
Open in API
Filings indexed 146 across all filing types
Latest filing 2022-10-19 Major Shareholding Noti…
Country KR South Korea
Listing KO 378800

About Shaperon Inc.

https://www.shaperon.com/

Shaperon Inc. is a clinical-stage biotechnology company that develops novel immune therapeutics for inflammatory diseases. The company's primary focus is on the development of innovative inflammasome inhibitors. Its core technology is based on a unique mechanism that modulates the GPCR19-P2X7 pathway to regulate the initiation and progression of inflammatory responses. This approach is applied to a pipeline of drug candidates targeting various inflammation-driven conditions.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed in South Korea. This type of filing is required under the Capital Markets Act when an entity acquires a significant stake (typically 5% or more) in a listed company. In the provided taxonomy, this corresponds to a 'Major Shareholding Notification'.
2022-10-19 Korean
증권발행실적보고서
Share Issue/Capital Change Classification · 100% confidence The document is a '증권발행실적보고서' (Report on the Results of Securities Issuance) filed with the Financial Supervisory Service (FSS) in South Korea. It details the final results of a public offering, including subscription and allocation data for institutional and retail investors, as well as underwriting information. This type of filing is a standard regulatory requirement following a capital raise or IPO, which falls under the 'Share Issue/Capital Change' category.
2022-10-12 Korean
[발행조건확정]증권신고서(지분증권)
Share Issue/Capital Change Classification · 95% confidence The document is a '증권신고서(지분증권) 정정신고서' (Securities Registration Statement - Amendment) filed with the Financial Services Commission (금융위원회) in South Korea. It details the finalization of the offering price (공모가액 확정) for Shaperon Co., Ltd. and provides updated information regarding the offering terms, allocation, and underwriting details. This type of regulatory filing for a public offering of securities falls under the 'Regulatory Filings' category as it is a formal legal document submitted to a regulatory body to update previously filed information.
2022-10-05 Korean
[기재정정]투자설명서
Capital/Financing Update Classification · 98% confidence The document is a 'Correction Report' (정정신고서) for a Securities Registration Statement (투자설명서) filed by Chaperon Co., Ltd. It details amendments to the public offering price, total offering amount, and allocation ratios following the determination of the final offering price. This is a formal regulatory filing related to a capital raising activity (IPO/Public Offering). In the context of the provided filing categories, this document is a regulatory filing regarding the issuance of shares and capital changes, which fits best under 'Share Issue/Capital Change' (SHA) or 'Regulatory Filings' (RNS). Given the specific focus on the offering price and share allocation details, 'SHA' is the most precise classification.
2022-10-05 Korean
투자설명서
Capital/Financing Update Classification · 95% confidence The document is a '투자설명서' (Investment Prospectus) for Shaperon Inc., dated September 29, 2022. It details the offering of common shares, including the offering price, subscription period, and payment date. It also contains extensive sections on investment risks, business overview, and financial information typical of a formal securities registration statement (증권신고서) and prospectus required for an IPO or public offering. In the context of financial filings, this document is a formal prospectus/offering document, which falls under the 'Proxy Solicitation & Information Statement' (PSI) category in many classification systems, but given the specific options provided and the nature of the document as a formal offering document for public subscription, it is best classified as a Proxy Solicitation & Information Statement (PSI) or a Regulatory Filing (RNS). However, since it is a formal investment prospectus for a public offering, 'PSI' is the most accurate fit for materials provided to potential investors for decision-making.
2022-09-29 Korean
[기재정정]증권신고서(지분증권)
Share Issue/Capital Change Classification · 95% confidence The document is a '증권신고서(지분증권) 정정신고' (Securities Registration Statement Amendment) for the company 'Chaperon'. It details amendments to the initial registration statement regarding public offering methods, demand forecasting, and capital structure. In the context of financial filings, a Securities Registration Statement (and its amendments) is a regulatory filing required for public offerings, which falls under the 'Regulatory Filings' category as it does not fit into the specific categories like 10-K, ER, or IP.
2022-09-27 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.